APC BIO INNOVATIONS INC
Frederick, MD · Biotech · Private
Recombinant human CC10 protein (rhCC10) therapeutic for chronic lung allograft dysfunction
apcbioinnovations.com →- Grants
- $778K
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Role of Secretoglobin 1A1 Protein in COVID-19-induced Thrombosis | $256,467 | |
| Federal grant | Department of Health and Human Services · Phase I · Recombinant human CC10 protein for treatment and prevention of chronic lung allograft dysfunction | $260,664 | |
| Federal grant | Department of Health and Human Services · Phase I · Recombinant human CC10 protein for treatment and prevention of chronic lung allograft dysfunction | $260,664 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2109 | AVIVA BIOSCIENCES CORP | — | $500K |
| 2110 | BE Biopharma | — | — |
| 2111 | FRUGI BIOTECHNOLOGY INC. | — | — |
| 2112 | APC BIO INNOVATIONS INC | — | — |
| 2113 | ABILITY DYNAMICS, L.L.C. | — | $1.5M |
| 2114 | REPRODUCTIVE STRESS; MEASUREMENT, MECHANISMS AND MANAGEMENT, CORPORATION | — | — |
| 2115 | BRIACELL THERAPEUTICS CORP | — | $34M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.